Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Norton

Showing results (151-160 of 201) with videos related to

Pageof 21
Sort By:
The Pediatric Infectious Disease Journal|February 12, 2004
Clinical predictors of bloodstream infections and mortality in hospitalized Malawian childrenElizabeth B Norton, Lennox K Archibald, Okey C Nwanyanwu, et al.
Medical Microbiology and Immunology|February 11, 2025
Protective antibodies against enterotoxigenic Escherichia coli are generated from heat-labile toxoid vaccination and exhibit subject- and vaccine-specific diversityMilton Maciel, Jordan C Scott, Robin L Baudier, et al.
STAR Protocols|December 8, 2024
Protocol for measuring anti-fentanyl antibodies in mouse serum by enzyme-linked immunosorbent assayJacob A Koster, Alejandra Prevost-Reilly, Dheeraj Soni, et al.
Journal of Comparative Pathology|January 27, 2023
Intralesional application of ribavirin in two American flamingos (Phoenicopterus ruber) with poxvirus infectionGiuseppe M Marcello, Kali A Holder, Sara Hallager, et al.
Scientific Reports|October 24, 2019
LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (μMT) miceE Valli, A J Harriett, M K Nowakowska, et al.
Infection and Immunity|January 12, 2021
Elevated Extracellular cGMP Produced after Exposure to Enterotoxigenic Escherichia coli Heat-Stable Toxin Induces Epithelial IL-33 Release and Alters Intestinal ImmunityNatalya I Motyka, Sydney R Stewart, Ian E Hollifield, et al.
Developmental Pharmacology and Therapeutics|January 1, 1980
Indomethacin treatment in patent ductus arteriosus. A double-blind study utilizing indomethacin plasma levelsR M Nestrud, D E Hill, R W Arrington, et al.
The British Journal of Surgery|April 1, 1993
New technique to measure mucosal metabolism and its use to map substrate utilization in the healthy human large bowelM A Chapman, M F Grahn, P Giamundo, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 1, 1979
Pulsatile perfusion versus conventional high-flow nonpulsatile perfusion for rapid core cooling and rewarming of infants for circulatory arrest in cardiac operationG D Williams, A B Seifen, N W Lawson, et al.
Vaccine|May 9, 2022
Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial" [Vaccine 40(19) (2022) 2705-2713]Jessica W Crothers, Elizabeth Ross Colgate, Kelly J Cowan, et al.
Pageof 21

Showing results (151-160 of 201) with videos related to

Sort By:
Pageof 21
The Pediatric Infectious Disease Journal|February 12, 2004
Clinical predictors of bloodstream infections and mortality in hospitalized Malawian childrenElizabeth B Norton, Lennox K Archibald, Okey C Nwanyanwu, et al.
Medical Microbiology and Immunology|February 11, 2025
Protective antibodies against enterotoxigenic Escherichia coli are generated from heat-labile toxoid vaccination and exhibit subject- and vaccine-specific diversityMilton Maciel, Jordan C Scott, Robin L Baudier, et al.
STAR Protocols|December 8, 2024
Protocol for measuring anti-fentanyl antibodies in mouse serum by enzyme-linked immunosorbent assayJacob A Koster, Alejandra Prevost-Reilly, Dheeraj Soni, et al.
Journal of Comparative Pathology|January 27, 2023
Intralesional application of ribavirin in two American flamingos (Phoenicopterus ruber) with poxvirus infectionGiuseppe M Marcello, Kali A Holder, Sara Hallager, et al.
Scientific Reports|October 24, 2019
LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (μMT) miceE Valli, A J Harriett, M K Nowakowska, et al.
Infection and Immunity|January 12, 2021
Elevated Extracellular cGMP Produced after Exposure to Enterotoxigenic Escherichia coli Heat-Stable Toxin Induces Epithelial IL-33 Release and Alters Intestinal ImmunityNatalya I Motyka, Sydney R Stewart, Ian E Hollifield, et al.
Developmental Pharmacology and Therapeutics|January 1, 1980
Indomethacin treatment in patent ductus arteriosus. A double-blind study utilizing indomethacin plasma levelsR M Nestrud, D E Hill, R W Arrington, et al.
The British Journal of Surgery|April 1, 1993
New technique to measure mucosal metabolism and its use to map substrate utilization in the healthy human large bowelM A Chapman, M F Grahn, P Giamundo, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 1, 1979
Pulsatile perfusion versus conventional high-flow nonpulsatile perfusion for rapid core cooling and rewarming of infants for circulatory arrest in cardiac operationG D Williams, A B Seifen, N W Lawson, et al.
Vaccine|May 9, 2022
Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial" [Vaccine 40(19) (2022) 2705-2713]Jessica W Crothers, Elizabeth Ross Colgate, Kelly J Cowan, et al.
Pageof 21